CAPhO Connections Podcast Series keeps the oncology pharmacy community informed on matters affecting you and updated on CAPhO’s news related to education, awards, advocacy, and research.
CAPhO Connections Podcast Series keeps the oncology pharmacy community informed on matters affecting you and updated on CAPhO’s news related to education, awards, advocacy, and research.
In this latest episode, Miranda So covers the topic of COVID-19 infection and treatment in patients with cancer and shares tips on preventing COVID-19 in cancer patients.
CAPhO Connections Podcast Series keeps the oncology pharmacy community informed on matters affecting you and updated on CAPhO’s news related to education, awards, advocacy and research. Whether it’s your morning commute to work, a walk in the park
Apobiologix, a division of Apotex Inc., expanded its product portfolio with the launch of a pre-filled autoinjector for Lapelga®, the company’s biosimilar pegfilgrastim that launched in Canada in 2019. Apobiologix, focused on the development of biosimilars for global markets, is the only biosimilar company to offer a pegfilgrastim autoinjector. The pre-filled syringe for Lapelga will continue to be available to patients.
Patients prescribed Fulphila have access to a multi-use and multi-patient copay program providing up to a maximum of 25% immediate financial assistance at pharmacy:
